Thank you, Chair, and thank you to our witnesses as well.
As I've listened this morning, I feel the discussion really has centred on so much that does work. SR and ED works, IRAP works—there are a lot of good tools and devices available to industry and to SMEs to develop product and get it to market.
My first question is to Mr. Abielmona, with regard to your comment that with these tools we get it to commercialization and there it stops. You talked about your valley of death. I come from a business background, so I wrestle with the responsibility between taxpayer risk and how we manage that versus the business risk of the entrepreneurs, SMEs, and developers that bring these products to market.
To your comment of bringing it to commercialization and hitting the wall at that point, what would you recommend in commercializing, in ensuring that we take what we think are fairly strong competitive advantages to market? What do we do at that point? What would you recommend?